Molecular alterations in anti-apoptotic BCL2 family proteins in breast cancer cell line models, drug sensitivities and dependencies to guide the development of BCL2 inhibitors-Reference-Cited by-同舟云学术

Molecular alterations in anti-apoptotic BCL2 family proteins in breast cancer cell line models, drug sensitivities and dependencies to guide the development of BCL2 inhibitors

Published:2022-12 Issue: Volume:847 Page:146881
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Voutsadakis Ioannis A.

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference40 articles.

1. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors;Ashkenazi;Nat Rev Drug Discov,2017

2. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity;Barretina;Nature,2012

3. Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens;Behan;Nature,2019

4. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data;Cerami;Cancer Discov,2012

5. OncoKB: A Precision Oncology Knowledge Base;Chakravarty;JCO Precision Oncology,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation and characterization of pH-sensitive chitosan/starch/MoS2 nanocomposite for control release of curcumin macromolecules drug delivery; application in the breast cancer treatment;International Journal of Biological Macromolecules;2023-10

2. Hyaluronic acid-engineered Bcl-2 inhibitor nanocrystals for site-specific delivery to breast tumor cells;Nanomedicine;2023-06

3. Breast cancer sub-types display heterogeneity in gene amplification and mRNA expression of the anti-apoptotic members of BCL2 family;Gene;2023-03